LYMPHOGENIX LIMITED

Registered Number
15704914
(England and Wales)

Unaudited Financial Statements for the Period ended
31 May 2025

LYMPHOGENIX LIMITED

Company Information
for the period from 7 May 2024 to 31 May 2025


Directors	IWAMIYA, Takahiro, Dr
	MATSUNAGA, Masashi, Dr


Registered Number	15704914 (England and Wales)

LYMPHOGENIX LIMITED

Balance Sheet as at
31 May 2025

		2025 £


Current Assets		8,507
Net current assets (liabilities)		8,507

Total assets less current liabilities		8,507

Accruals and deferred income		(660)
Net assets (liabilities)		7,847
Capital and reserves		7,847

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Average number of employees
The average number of persons employed by the company in the period was 0.

The financial statements were approved and authorised for issue by the Board of Directors on 30 October 2025, and are signed on its behalf by:

IWAMIYA, Takahiro, Dr
Director

MATSUNAGA, Masashi, Dr
Director

Registered Company No. 15704914